Across pharmaceutical laboratories, a silent cost often goes unnoticed. It's the financial burden associated with underutilized equipment. Acquiring sophisticated instruments is a substantial expense, yet these tools often sit idle due to factors like shifting research priorities. This stagnation translates into lost time, lowered productivity, and